Sirna Therapeutics, Inc. (RNAI, breakthrough - a 95% knockdown of hepatitis B virus (HBV

This is the first demonstration of systemic siRNA efficacy at therapeutically relevant doses and establishes a strong scientific foundation for broad human application of RNAi-based therapeutics.

ClearStation : News Articles : RNAI

BioBOOM Op/Ed: This should stimulate the "value" of companies with IP in the siRNA area, as some of us have predicted. Will be interesting to watch these developments = keep your powder dry.

1 comment:

acid-bomb said...

Hype blog. And I admire your site and plan on
returning to it! When I web surf it always helps me to
find great blogs.
Please take a journey to my low fee cash advance blog.

Blog Archive